changes in serum markers of tissue damage after Extra corporeal shock wave lithotripsy in patients with kidney stones

Survey of changes in serum markers of tissue damage after Extra corporeal shock wave lithotripsy in patients with kidney stones referred to lithotripsy center of Zabol in 1395

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016082328927N2

Enrollment

120

Registered

2016-11-15

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone. Calculus of kidney with calculus of ureter

Interventions

Demographic information of the patients is recorded and then before lithotripsy and 3 hours and 24 hours after ESWL 5 cc of blood sample are collected and then are transferred into clot activator tub

Eligibility

Sex/Gender

All

Age

12 Years to 69 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having age between 12 to 70 years. exclusion criteria: chronic kidney disease and liver; pancreatitis; infections.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Alanine aminotransferase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Aspartate aminotransferase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Alkaline phosphatase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Amylase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Lipase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Cardiac enzyme troponin I. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Cpk-mb enzymes. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;The enzyme CPK-total. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Bilirubin. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Albumin. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.	—

Measure

Time frame

Alanine aminotransferase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Aspartate aminotransferase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Alkaline phosphatase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Amylase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Lipase. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Cardiac enzyme troponin I. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Cpk-mb enzymes. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;The enzyme CPK-total. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Bilirubin. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.;Albumin. Timepoint: before ESWL; 3 and 24 houre after ESWL. Method of measurement: Blood samples.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhajehmahmood Fatemeh

Zabul Medical Sciences

fatemekhaje34@gmail.com+98 54 3229 5125

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026